Stay updated on PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Sign up to get notified when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.

Latest updates to the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page
- Check3 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a technical release rather than new study information.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No visible changes to the study details or page functionality.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 added. The notice about government funding and operating status was removed.SummaryDifference0.2%

- Check82 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision to v3.4.1, removing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.